Thomas Hensing

Thomas Hensing

UNVERIFIED PROFILE

Are you Thomas Hensing?   Register this Author

Register author
Thomas Hensing

Thomas Hensing

Publications by authors named "Thomas Hensing"

Are you Thomas Hensing?   Register this Author

55Publications

1313Reads

34Profile Views

A Predictive 7-Gene Assay and Prognostic Protein Biomarkers for Non-small Cell Lung Cancer.

EBioMedicine 2018 Jun 1;32:102-110. Epub 2018 Jun 1.

National Institute of Occupational Safety and Health, 1095 Willowdale Road, Morgantown, WV 26505, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2018.05.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020749PMC
June 2018

KRAS in Non-Small-Cell Lung Cancer-Reply.

JAMA Oncol 2016 10;2(10):1373-1374

City of Hope, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.2347DOI Listing
October 2016

Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck.

Expert Rev Anticancer Ther 2016 Aug 11;16(8):847-58. Epub 2016 Jul 11.

a Kellogg Cancer Center , NorthShore University HealthSystem , Evanston , IL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2016.1202116DOI Listing
August 2016

Prognostic and Predictive Value in KRAS in Non-Small-Cell Lung Cancer: A Review.

JAMA Oncol 2016 Jun;2(6):805-12

City of Hope Comprehensive Cancer Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.0405DOI Listing
June 2016

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.

J Clin Oncol 2016 Mar 4;34(9):987-1011. Epub 2016 Feb 4.

Don S. Dizon, Massachusetts General Hospital, Boston; Erica Mayer, Dana-Farber Cancer Institute, Boston, MA; Lada Krilov and Richard Schilsky, American Society of Clinical Oncology, Alexandria, VA; Ezra Cohen, University of California San Diego, San Diego; Patricia A. Ganz, University of California Los Angeles, Los Angeles; Sumanta Kumar Pal, City of Hope Comprehensive Cancer Center, Duarte, CA; Tara Gangadhar, University of Pennsylvania; Stephen Hunger, Children's Hospital Center of Philadelphia, Philadelphia, PA; Thomas A. Hensing, University of Chicago, Evanston, IL; Smitha S. Krishnamurthi, Case Western Reserve University, Cleveland, OH; Andrew B. Lassman and Gary K. Schwartz, Columbia University; David R. Spriggs, Memorial Sloan Kettering Cancer Center; Gina Villani, Ralph Lauren Center for Cancer Care and Prevention, New York, NY; Merry Jennifer Markham, University of Florida, Gainesville; Miguel Angel Villalona-Calero, Miami Cancer Institute, Miami, FL; Michael Neuss, Vanderbilt-Ingram Cancer Center, Nashville, TN; Lisa C. Richardson, Centers for Disease Control and Prevention, Atlanta, GA; and Gregory Masters, Helen F. Graham Cancer Center and Research Institute, Newark, DE.

View Article

Download full-text PDF

Source
http://news.medlive.cn/uploadfile/20160205/14546422512856.pd
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.65.8427
Publisher Site
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075244PMC
http://dx.doi.org/10.1200/JCO.2015.65.8427DOI Listing
March 2016

Promotion of self-management for post treatment cancer survivors: evaluation of a risk-adapted visit.

J Cancer Surviv 2016 Feb 16;10(1):206-19. Epub 2015 Jul 16.

Highland Park Hospital, NorthShore University HealthSystem, 777 Park Avenue West Room 1170, Highland Park, IL, 60035, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11764-015-0467-6DOI Listing
February 2016

Buccal spectral markers for lung cancer risk stratification.

PLoS One 2014 9;9(10):e110157. Epub 2014 Oct 9.

Department of Medicine, Boston University, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0110157PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192585PMC
December 2015

Lung cancer-a fractal viewpoint.

Nat Rev Clin Oncol 2015 Nov 14;12(11):664-75. Epub 2015 Jul 14.

Section of Hematology/Oncology, University of Chicago, 5841 South Maryland Avenue, MC 2115 Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2015.108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989864PMC
November 2015

Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.

J Thorac Oncol 2015 Jan;10(1 Suppl 1):S1-63

*Department of Medical Oncology, Washington University School of Medicine, Saint Louis, Missouri; Departments of †Medical Oncology and ‡Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts; §Department of Medical Oncology, University of Colorado School of Medicine and University of Colorado Cancer Center, Aurora, Colorado; ‖UCLA Santa Monica Hematology Oncology, Santa Monica, California; ¶Division of Hematology-Oncology, Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas; #Department of Medical Oncology, Yale School of Medicine and Cancer Center, New Haven, Connecticut; **Massachusetts General Hospital Cancer Center, Boston, Massachusetts; ††Department of Oncology, The University of Chicago Medicine, Chicago, Illinois; ‡‡Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee; §§Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, Georgia; ‖‖Memorial Sloan-Kettering Cancer Center, New York, New York; ¶¶Division of Hematology-Oncology, Medical University of South Carolina, Charleston, South Carolina; ##Sarah Cannon Research Institute, Nashville, Tennessee; ***The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; †††Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas; and ‡‡‡Division of Medical Oncology, University of Colorado Denver School of Medicine, Denver, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000405DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346098PMC
January 2015

A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization.

Adv Exp Med Biol 2014 ;799:85-117

Department of Medicine, Section of Hematology/Oncology, NorthShore University Health System, Kellogg Cancer Center, 2650 Ridge Avenue, Evanston, IL, 60201, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4614-8778-4_5DOI Listing
April 2014

Molecular biomarkers for future screening of lung cancer.

J Surg Oncol 2013 Oct 25;108(5):327-33. Epub 2013 Jul 25.

NorthShore University HealthSystem, Clinical Associate Professor of Medicine, University of Chicago Pritzker, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.23382DOI Listing
October 2013

Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study.

J Clin Oncol 2013 Sep 26;31(27):3320-6. Epub 2013 Aug 26.

Glenwood D. Goss and Ian Lorimer, Ottawa Hospital Cancer Center, University of Ottawa, Ottawa; Chris O'Callaghan and Keyue Ding, NCIC CTG, Queens University, Kingston; Ming-Sound Tsao and Frances A. Shepherd, University Health Network, Princess Margaret Hospital, University of Toronto, Toronto; Jonathan Noble, Northeast Cancer Center, Sudbury, Ontario; Charles Butts, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada; Gregory A. Masters, Christiana Care's Helen F. Graham Cancer Center, Newark, DE; James Jett, National Jewish Health, Division of Oncology, Denver, CO; Martin J. Edelman, Greenebaum Cancer Center, University of Maryland, Baltimore, MD; Rogerio Lilenbaum, Smilow Cancer Hospital, Yale Cancer Center, New Haven, CT; Hak Choy, Kemp Kernstine, and Joan Schiller, The University of Texas, Southwestern Medical Center, Dallas; Katherine Pisters, The University of Texas MD Anderson Cancer Center, Houston, TX; Fadlo Khuri, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA; David Gandara, University of California, Davis Cancer Center, Sacramento, CA; Thomas A. Hensing, NorthShore University Health System, The University of Chicago, Chicago; and Kendrith Rowland, Carle Cancer Center, Urbana, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.1816DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770864PMC
September 2013

A brief symptom index for advanced lung cancer.

Clin Lung Cancer 2012 Jan 23;13(1):14-23. Epub 2011 May 23.

Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2011.03.033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486486PMC
January 2012

A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer.

J Thorac Oncol 2011 Sep;6(9):1569-77

Division of Hematology/Oncology, Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3182210430DOI Listing
September 2011

Effect of an electronic health record on the culture of an outpatient medical oncology practice in a four-hospital integrated health care system: 5-year experience.

J Oncol Pract 2011 Jul;7(4):e20-4

Department of Medicine, Division of Hematology/Oncology; Pharmacy; and Administration, NorthShore University HealthSystem, Evanston; Department of Medicine, University of Chicago Pritzker School of Medicine, Chicago, IL.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.2011.000260
Publisher Site
http://dx.doi.org/10.1200/JOP.2011.000260DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140456PMC
July 2011

Personalized treatment of lung cancer.

Semin Oncol 2011 Apr;38(2):274-83

Department of Medicine, The University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2011.01.012DOI Listing
April 2011

A multicenter phase II trial of carboplatin and cetuximab for treatment of advanced nonsmall cell lung cancer.

Cancer Invest 2010 Feb;28(2):208-15

Multidisciplinary Thoracic Oncology Program at Lineberger Comprehensive Cancer Center at the University of North Carolina, Physicians Office Building, 3rd Floor 170 Manning Drive, Cb 7305, Chapel Hill, NC 27599-7305, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/0735790090328695
Publisher Site
http://dx.doi.org/10.3109/07357900903286958DOI Listing
February 2010

Prevalence of poor performance status in lung cancer patients: implications for research.

J Thorac Oncol 2008 Feb;3(2):125-9

Thoracic Oncology Program, Mount Sinai Cancer Center, Miami Beach, Florida 33140, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181622c17DOI Listing
February 2008

The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected non-small cell lung cancer.

J Thorac Oncol 2008 Feb;3(2):145-51

Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318160c5f1DOI Listing
February 2008

Relationship between symptom change, objective tumor measurements, and performance status during chemotherapy for advanced lung cancer.

Clin Lung Cancer 2008 Jan;9(1):51-8

Center on Outcomes, Research, and Education, Evanston Northwestern Healthcare, Illinois, Institute for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2008.n.009DOI Listing
January 2008

Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition).

Chest 2007 Sep;132(3 Suppl):277S-289S

Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, CB# 7305, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.07-1381DOI Listing
September 2007

An innovative symptom monitoring tool for people with advanced lung cancer: a pilot demonstration.

J Support Oncol 2007 Sep;5(8):381-7

Georgetown University Medical Center, Department of Oncology, Lombardi Comprehensive Cancer Center, Washington, DC 20007, USA.

View Article

Download full-text PDF

Source
September 2007

Efficacy and safety of gefitinib in chemonaive patients with advanced non-small cell lung cancer treated in an Expanded Access Program.

Lung Cancer 2006 Sep 23;53(3):331-7. Epub 2006 Jun 23.

Washington University School of Medicine, Department of Medical Oncology, 660 S. Euclid Ave. (Box 8056), St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2006.04.013DOI Listing
September 2006

Phase II study of BBR 3464 as treatment in patients with sensitive or refractory small cell lung cancer.

Anticancer Drugs 2006 Jul;17(6):697-704

Kellogg Cancer Center, Evanston Northwestern Healthcare, Evanston, Illinois 60201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.cad.0000215054.62942.7fDOI Listing
July 2006

Combined analysis of molecular and clinical predictors of gefitinib activity in advanced non-small cell lung cancer: epidermal growth factor receptor mutations do not tell the whole story.

J Thorac Oncol 2006 Jan;1(1):52-60

Division of Hematology-Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
January 2006

Clinical evaluation and staging of patients who have lung cancer.

Authors:
Thomas A Hensing

Hematol Oncol Clin North Am 2005 Apr;19(2):219-35, v

Feinberg School of Medicine, Northwestern University, 2650 Ridge Avenue, Evanston, IL 60201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2005.02.010DOI Listing
April 2005

A phase II trial of weekly paclitaxel and gemctiabine infused at a constant rate in patients with advanced non-small cell lung cancer.

Lung Cancer 2005 Mar;47(3):413-9

Department of Hematology/Oncology, University of Virginia Health Services, 6th Floor Multistory Building, Room 6007, Charlottesville, VA 22908, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2004.08.009DOI Listing
March 2005

Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer.

Lung Cancer 2005 Feb;47(2):253-9

Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2004.07.040DOI Listing
February 2005

Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer.

J Clin Oncol 2004 Dec;22(23):4837-45

Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2004.01.178
Publisher Site
http://dx.doi.org/10.1200/JCO.2004.01.178DOI Listing
December 2004

Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness < or =1.0 mm).

Ann Surg Oncol 2004 Oct 20;11(10):900-6. Epub 2004 Sep 20.

Division of Surgical Oncology, Department of Surgery, 3010 Old Clinic Building, CB#7213, University of North Carolina, Chapel Hill, NC 27599-7213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/ASO.2004.10.002DOI Listing
October 2004

The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel.

Cancer 2003 Aug;98(4):779-88

Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.11548
Publisher Site
http://dx.doi.org/10.1002/cncr.11548DOI Listing
August 2003

Duration of therapy in advanced, metastatic non-small-cell lung cancer.

Clin Adv Hematol Oncol 2003 Jan;1(1):33-8

Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599-7305, USA.

View Article

Download full-text PDF

Source
January 2003

Clinical applications of proton MR spectroscopy in oncology.

Technol Cancer Res Treat 2002 Feb;1(1):17-28

Department of Radiology, Lineberger Comprehensive Cancer Center, University of North Carolina, School of Medicine, Chapel Hill NC 27599-7515, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/153303460200100103DOI Listing
February 2002